首页|青黄散治疗髓系肿瘤的临床研究进展

青黄散治疗髓系肿瘤的临床研究进展

Clinical Research Progress of Qinghuang Powder in the Treatment of Myeloid Tumors

扫码查看
髓系肿瘤(Myeloid neoplasms)是一组异质性疾病,肿瘤细胞起源于骨髓中具有多向分化潜能的造血干细胞,并出现克隆性增殖.从20世纪70年代中期开始,诸多经典中药方剂,临床运用效果明显,而青黄散作为代表,通过大量临床数据证实该方治疗髓系肿瘤有效,为古方中药的发掘与研究提供指引,然而如何将中医的研究成果科学化、全球化,是机遇也是挑战.
Myeloid neoplasms are heterogeneous diseases in which myeloid neoplasms are derived from hematopoietic stem cells with the potential for multidifferentiation and clonal proliferation in the bone marrow.Since the mid-1970s,many classical Chinese medicine prescriptions have shown obvious clinical application effects,and Qinghuang SAN,as a representative,has proved its effectiveness in the treatment of myeloid tumors through a large number of clinical data,providing guidance for the dis-covery and research of ancient Chinese medicine.However,how to scientize and globalize the research results of Chinese medi-cine is both an opportunity and a challenge.

qinghuang sanmyeloid tumorinheritancedevelop-ment

邓来军、董杨、刘丽娟、周超、孙伟国、孙长岗

展开 >

潍坊市中医院,山东 潍坊 261000

安丘海吉亚医院,山东 安丘 262124

青黄散 髓系肿瘤 传承 发展

国家自然科学基金山东省中医药科技项目

821742222021M088

2024

实用中医内科杂志
辽宁省中医药学会,中华中医药学会,辽宁省中医药研究院

实用中医内科杂志

影响因子:0.421
ISSN:1671-7813
年,卷(期):2024.38(4)
  • 43